Skip to main content Skip to section navigation Skip to footer
Stock Information
chevron_leftBack to definiumtx.com
Definium Therapeutics IR Overview
  • Investors
  • News & Events
    • Press Releases
    • IR Calendar
    • Presentations
    • Email Alerts
  • About
    • Management
    • Contacts
    • FAQ
  • Financial Results
  • Stock Data
    • Quote & Chart
    • Historical Data
  • Analyst Coverage
  • SEC Filings
    • All SEC Filings
    • Annual Reports
    • Quarterly Reports
    • Section 16 Filings
  • Corporate Governance
    • Board of Directors
    • Board Committees
    • Governance Documents
  • SEDAR
  • Stock Information
  • chevron_leftBack to definiumtx.com

IR Calendar

News & Events

News & Events

  • Press Releases
  • IR Calendar
  • Presentations
  • Email Alerts

Phase 3 Voyage Topline Results: DT120 ODT in Generalized Anxiety Disorder

Aug 12, 2026 8:00 am EDT
WebcastAudio
PresentationPDF
  • emailEmail Alerts
  • contact_pageContacts
  • rss_feedRSS News Feed
  • account_treeSitemap
©2026 Definium Therapeutics. All Rights Reserved.
  • Privacy Notice
  • Disclaimer
  • Sitemap
  • Accessibility Statement

Market Data copyright © 2026 QuoteMedia. Data delayed 15 minutes unless otherwise indicated (view delay times for all exchanges). RT=Real-Time, EOD=End of Day, PD=Previous Day. Market Data powered by QuoteMedia. Terms of Use.